PATENT CLAIM ANALYSIS

Application Number: 15916371
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "769000"]

Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.

Claim (Index 7):
A method of treating multiple sclerosis in a patient in need thereof, comprising administering a therapeutically effective amount of the solid pharmaceutical composition according to  claim 1 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14009241', '12189323', '14842517', '11198710', '14435346']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6922229217312406
- 35 USC 102 Novelty (BERT): 0.53671714517853
- Combined Prediction Score: 0.6766723440759695
- Mean Citation Score: 191.739828
- Max Citation Score: 344.9039
- Similarity Product: 226.92225858225825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test